Back to top

Supplemental Agreement to the Subscription and Shareholders' Agreement relating to Molecular Vision Limited (the "Company")

Addendum or Modifications

Supplemental Agreement to the Subscription and Shareholders' Agreement relating to Molecular Vision Limited (the You are currently viewing:
This Addendum or Modifications involves

ACRONGENOMICS INC | Imperial Innovations Businesses LLP | Molecular Vision Limited

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Supplemental Agreement to the Subscription and Shareholders' Agreement relating to Molecular Vision Limited (the "Company")
Date: 11/20/2008
Industry: Biotechnology and Drugs     Sector: Healthcare

Supplemental Agreement to the Subscription and Shareholders' Agreement relating to Molecular Vision Limited (the
50 of the Top 250 law firms use our Products every day

[On headed paper of Molecular Vision Limited]

Professor Donal Bradley
Rose Garth, Old Long Grove
Seer Green, Beaconsfield
Buckinghamshire HP9 2QH
United Kingdom

Professor Andrew DeMello
64 Hamilton Road
Middlesex TW2 6SN
Untied Kingdom

Dr John DeMello
Flat 9, The Chase
Clapham, London SW4 0NH
United Kingdom

Imperial Innovations Limited
Level 12 Electrical Engineering Building
Imperial College London
London SW7 2AZ
United Kingdom
0

Imperial Innovations Businesses LLP ( "Imperial" )
Level 12 Electrical Engineering Building
Imperial College London
London SW7 2AZ
United Kingdom

Acrongenomics Inc.
( "Acrongenomics" )
Fairfax House
15 Fulwood Place
London WC1V 6AY
United Kingdom

Christopher Wright
( "Mr Wright" )

 

                2008

Dear Sirs

Supplemental Agreement to the Subscription and Shareholders' Agreement relating to Molecular Vision Limited (the "Company")

This letter agreement is supplemental to the subscription and shareholders' agreement entered into by the Company and certain of you on 30 July 2007 and adhered to by Imperial, Acrongenomics and Mr Wright on [ ], [ ] and [ ] respectively (the "Shareholders' Agreement" ). The purpose of this letter agreement is to set out various amendments and additions to the Shareholders' Agreement.

Acrongenomics Inc. Board Seat Rights

Pursuant to a letter agreement dated 19 August 2008 entered into between the Company, you and Acrongenomics, it is agreed that Acrongenomics shall be entitled to appoint a director to the board of the Company for so long as it holds at least 15% of the shares of the Company in issue. By signing this letter, you agree to the insertion of the following new clauses in the Shareholders' Agreement in the following terms:

14.3A

Subject to prior approval by the Board (such approval not to be unreasonably withheld) of the identity of the proposed appointee, Acrongenomics shall be entitled to appoint (for long as it holds at least 15% of the Shares in issue) as a director of the Company any person and to remove fr


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more